Eneda Toska
Memorial Sloan-Kettering Cancer Center
3 papers found
Refreshing results…
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
UploadNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
UploadMissing publications? Search for publications with a matching author name.